Omega Therapeutics
Biotechnology, 900 Rockmead Dr, Cambridge, Massachusetts, 77339, United States, 51-200 Employees
Phone Number: 61********
Who is OMEGA THERAPEUTICS
Omega Therapeutics is a clinical-stage biotechnology company pioneering the first systematic approach of using mRNA as programmable epigenomic medicines. Our OMEGA platform harnesses the ...
Read More
-
Headquarters: 900 Rockmead Dr, Cambridge, Massachusetts, 77339, United States
-
Date Founded: 2017
-
Employees: 51-200
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8721
Does something look wrong? Fix it. | View contact records from OMEGA THERAPEUTICS
Omega Therapeutics Org Chart and Mapping
Email
Phone
Similar Companies to Omega Therapeutics
Beam Therapeutics
-
501-1000
-
$ 50 Million to 100 Million
Cellarity
-
51-200
-
$ 1 Million to 5 Million
Flagship Pioneering
-
201-500
-
$ 500 Million to 1 Billion
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Omega Therapeutics
Answer: Omega Therapeutics's headquarters are located at 900 Rockmead Dr, Cambridge, Massachusetts, 77339, United States
Answer: Omega Therapeutics's phone number is 61********
Answer: Omega Therapeutics's official website is https://omegatherapeutics.com
Answer: Omega Therapeutics's revenue is $5 Million to $10 Million
Answer: Omega Therapeutics's SIC: 8721
Answer: Omega Therapeutics has 51-200 employees
Answer: Omega Therapeutics is in Biotechnology
Answer: Omega Therapeutics top competitors include: Beam Therapeutics , Cellarity , Flagship Pioneering
Answer: Omega Therapeutics contact info: Phone number: 61******** Website: https://omegatherapeutics.com
Answer: Omega Therapeutics is a clinical-stage biotechnology company pioneering the first systematic approach of using mRNA as programmable epigenomic medicines. Our OMEGA platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omegas engineered, modular, and programmable mRNA medicines, Omega Epigenomic ControllersTM, target specific intervention points amongst the thousands of mapped and validated novel DNA-sequence-based epigenomic loci to durably tune single or multiple genes to treat and cure disease through unprecedented precision epigenomic control. Omega has a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month